IFNG and neoplasm: Moreover, when used in conjunction with anti-PD1, LD4172 reshapes the tumor immune microenvironment by enhancing the infiltration of dendritic cells and IFNγ+ T cells, as well as by promoting the secretion of immunostimulatory cytokines, leading to antitumor effects.